Clinical Trials Resource Center

Chronic Shoulder Pain

September 16, 2002

Results of Entropin's study of Esterom, an investigational drug for the treatment of acute shoulder pain, indicated that subjects treated with 10% Esterom showed clinical improvements. However, these results were not statistically significant when compared with subjects treated with placebo. The double-blinded placebo-controlled phase II/III trial, enrolled 173 subjects in 10 sites throughout the U.S. Each subject was treated on three consecutive days with a dosage of 10% Esterom or placebo control. Based on these results, Entropin has decided to forego further development of Esterom.

Related Medical Areas

This information does not represent a Lupus Research Institute endorsement of any listed study. It is merely a notice that the study is available. If you are presently under the care of a physician for lupus or other conditions, you should not disrupt your current program without discussing it with your doctor(s). Do not contact the Lupus Research Institute for information on these studies. Only contact the listed numbers. The Lupus Research Institute does not have any jurisdiction over or further involvement with these studies, other than to make people aware that they are being conducted.